Cohort study to assess risk factors for atrial fibrillation
An Epidemiologic, Prospective, Single Center Cohort Study for the Improvement of Atrial Fibrillation Risk Stratification in High Risk Individuals
This study is trying to find out what factors might increase the risk of developing atrial fibrillation in people who are already considered high risk.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | Universitätsklinikum Hamburg-Eppendorf Academic / other |
| Locations | 1 site (Hamburg) |
| Trial ID | NCT05442970 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate and enhance the prediction of atrial fibrillation (AF) risk by considering a wide range of factors, including clinical, psycho-social, environmental, and lifestyle influences, as well as protein patterns and genetic variability. It is a prospective, single-center cohort study focused on patients identified as high risk for AF. The primary endpoint is the occurrence of AF, whether paroxysmal or permanent, allowing for a comprehensive understanding of risk factors associated with this condition.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 18 to 85 years who are at high risk for atrial fibrillation.
Not a fit: Patients who are unable to understand the study documents due to language barriers or those with physical or psychological conditions that prevent cooperation may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved risk stratification and management strategies for patients at risk of atrial fibrillation.
How similar studies have performed: While this approach is comprehensive, similar studies focusing on risk stratification for atrial fibrillation have shown promise in improving patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 to 85 years; * Personally signed informed consent Exclusion Criteria: * Insufficient knowledge of the German language, in order to understand study documents and computer assisted interview without translation; * Physical or psychological incapability to cooperate in the investigations
Where this trial is running
Hamburg
- Department of Cardiology, University Medical Center Hamburg-Eppendorf — Hamburg, Germany (Recruiting)
Study contacts
- Principal investigator: Renate B Schnabel, Prof. — Department of Cardiology, University Medical Center Hamburg-Eppendorf
- Study coordinator: Renate B Schnabel, Prof.
- Email: r.schnabel@uke.de
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.